35 completed, 1 active not recruiting, 1 not yet recruiting, 1 suspended. 41 Phase 3, 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 41 | Completed 35, Active not recruiting 1, Not yet recruiting 1, Suspended 1, Terminated 1, Unknown 1, Withdrawn 1 |
| Phase 2 | 6 | Completed 4, Suspended 1, Unknown 1 |
Follow Behavior Therapy: new trials by email Literature Review of Behavior Therapy trials Research Report on Behavior Therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3 Trial Evaluating the Efficacy and Safety of Cytisinicline for Vaping Cessation in Adults Using Nicotine-Containing E Cigarettes Cytisinicline, Placebo, Behavioral Support - Vaping Cessation | Phase 3 | Not yet recruiting | Achieve Life Sciences | 800 | 2026-05-15 | 2026-02-06 |
| Telehealth-Enabled Versus In-Person Parent-Mediated Behavioral Treatment for Challenging Behaviors in Children With ASD Behavior therapy, Psychoeducation - Autism Spectrum Disorder | Phase 2 / Phase 3 | Unknown | Stanford University | 90 | 2024-01-05 | 2024-08-27 |
| A Second Study of Cytisinicline for Smoking Cessation in Adult Smokers Cytisinicline, Placebo, Behavioral support - Smoking Cessation | Phase 3 | Completed | Achieve Life Sciences | 792 | 2022-01-20 | 2026-01-14 |
| Comparing Brief Behavioral Therapy (BBT-CI) and Healthy Eating Education Learning (HEAL) for Cancer-Related Sleep Problems While Receiving Cancer Treatment Behavioral Intervention, Electronic Health Record Review, Quality-of-Life Assessment - Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm | Phase 3 | Active not recruiting | University of Rochester NCORP Research Base | 400 | 2021-06-24 | 2026-04-24 |
| A Study of Cytisinicline for Smoking Cessation in Adult Smokers Cytisinicline, Placebo, Behavioral support - Smoking Cessation | Phase 3 | Completed | Achieve Life Sciences | 810 | 2020-10-13 | 2026-01-15 |
| Efficacy of Phosphatidylcholine in NAFLD Phosphatidyl Choline, Lifestyle modification - Non-Alcoholic Fatty Liver Disease | Phase 3 | Completed | Nehal Abou Seada | 100 | 2016-01-02 | 2020-06-04 |
| Effects of Self-conditioning Techniques in Promoting Weight Loss in Patients With Obesity. A Randomized Controlled Trial self-conditioning techniques, standard care (diet, exercise and behavioral therapy) - Obesity | Phase 3 | Completed | University of Turin, Italy | 120 | 2015-02-01 | 2018-01-24 |
| Assessing the Effectiveness of Two Treatment Strategies for Tension-type Headache Behavioral therapy, splint therapy and physical therapy, Standard care using current drugs - Tension-type Headache | Phase 3 | Withdrawn | University of Minnesota | 2012-04-01 | 2016-12-07 | |
| Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission Behavioral Intervention, Compliance Monitoring, Laboratory Biomarker Analysis - Acute Lymphoblastic Leukemia | Phase 3 | Completed | Children's Oncology Group | 570 | 2012-02-21 | 2026-07-31 |
| Novel Approach to Stimulant Induced Weight Suppression and Its Impact on Growth behavior therapy, Extended release (ER) methylphenidate product, monitoring - ADHD, Growth | Phase 3 | Completed | Florida International University | 230 | 2010-11-01 | 2017-07-14 |
| Efficacy of Behavioral Therapy and Exercise in Gestational Diabetes Mellitus (GDM) Behavioral therapy, Exercise, Behavioral therapy and exercise - Birth-weight | Phase 3 | Completed | University of Turin, Italy | 200 | 2009-07-01 | 2013-01-23 |
| A Randomized Trial Comparing Two Doses of Portion-Controlled Foods Within a Primary Care Weight Loss Program Weight loss counseling, Portion-Controlled Foods - Obesity | Phase 2 / Phase 3 | Completed | Kaiser Permanente | 50 | 2009-05-01 | 2020-01-30 |
| A Behavioral Intervention to Decrease Vomiting and Improve Weight Loss in Post-Operative Laparoscopic Adjustable Gastric Banding (LAGB) Patients behavioral intervention - Bariatric Surgery Complications | Phase 2 / Phase 3 | Suspended | The Miriam Hospital | 5 | 2009-05-01 | 2013-05-22 |
| Testing of INSTI™ HIV-1 Antibody Test Kit in Volunteer Subjects at Risk for HIV Infection Behavioral counseling, HIV-1 Antibody Test Kit - HIV Infections | Phase 2 / Phase 3 | Completed | bioLytical Laboratories | 2500 | 2007-07-01 | 2021-01-27 |
| Treatment of Childhood Obesity in Primary Care Motivational Interviewing (physicians), Behavior Modification (families) - Obesity | Phase 3 | Completed | University of Wisconsin, Madison | 145 | 2006-05-01 | 2015-10-02 |
| Educational Intervention on Weight Management in Chinese-American Children behavioral intervention - Overweight | Phase 3 | Completed | University of California, San Francisco | 80 | 2006-05-01 | 2009-08-18 |
| ATLAS: Ambulatory Treatments for Leakage Associated With Stress Behavioral Therapy, Intravaginal Pessary, Pessary combined with behavioral therapy - Stress Urinary Incontinence, Urinary Incontinence | Phase 3 | Completed | NICHD Pelvic Floor Disorders Network | 445 | 2005-06-01 | 2018-05-30 |
| Behavioral Treatment of Overactive Bladder in Men Behavioral training, Oxybutynin chloride, extended-release - Overactive Bladder | Phase 3 | Completed | US Department of Veterans Affairs | 143 | 2005-01-01 | 2014-05-20 |
| Job-Seekers Training for Patients With Drug Dependence - 1 Behavior Therapy - Substance-Related Disorders | Phase 3 | Completed | Johns Hopkins University | 627 | 2004-12-01 | 2017-01-12 |
| HIV and HCV Intervention In Drug Treatment Settings - 1 Behavior Therapy - Behavior Therapy | Phase 3 | Completed | University of Colorado, Denver | 706 | 2004-11-01 | 2017-01-12 |
Showing 20 of 41. Sign in to see all of them.
Substance-Related Disorders (9) · Obesity (4) · HIV Infections (2) · Obsessive-Compulsive Disorder (2) · Overweight (2) · Smoking Cessation (2) · Urinary Incontinence (2) · Acquired Immunodeficiency Syndrome (1) · Attention Deficit Disorder with Hyperactivity (1) · Autism Spectrum Disorder (1) · Behavior (1) · Birth Weight (1) · Cardiovascular Diseases (1) · Chronic Pain (1) · Cystic Fibrosis (1)
Achieve Life Sciences (3) · Johns Hopkins University (3) · Yale University (3) · Butler Hospital (2) · New York State Psychiatric Institute (2) · University of Turin, Italy (2) · University of Washington (2) · Children's Oncology Group (1) · Duke University (1) · Florida International University (1) · Kaiser Permanente (1) · Massachusetts General Hospital (1) · NICHD Pelvic Floor Disorders Network (1) · National Heart, Lung, and Blood Institute (NHLBI) (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (34) · Italy (2) · Germany (1) · Puerto Rico (1)
Kathleen Carroll, Ph.D. (3) · Maxine Stitzer, Ph.D. (2) · Michael Stein, M.D. (2) · Adam G Tsai, MD, MSCE (1) · Barbara Milrod, M.D. (1) · Chesney M, Coates T (1) · Dace Svikis, Ph.D. (1) · Daniel Cain, Vice-President Clinical Research (1) · Denise Hien, Ph.D. (1) · Dennis C. Turk, PhD (1) · Donald Calsyn, Ph.D. (1) · Ellen R. Wald, M.D. (1) · Eric L Schiffman, DDS (1) · Gerhard Ehninger, MD (1) · Holly E Richter, PhD, MD (1)
PMID 40962497, PMID 15234855, PMID 17592913, PMID 18645513, PMID 19026262, PMID 19150206, PMID 19375574, PMID 19452271, PMID 19634955, PMID 19805710, PMID 19917596, PMID 20078464, PMID 20155608, PMID 20177294, PMID 21185685, PMID 21344495, PMID 21854271, PMID 21861607, PMID 22024003, PMID 22092152, PMID 22182262, PMID 22453323, PMID 22914396, PMID 22959335, PMID 23318127, PMID 23431210, PMID 23448285, PMID 23558158, PMID 23774008, PMID 23795877, PMID 24313246, PMID 24439950, PMID 24724878, PMID 25646328, PMID 25735200, PMID 27217791, PMID 27739935, PMID 27802114, PMID 28254158, PMID 28714183, PMID 29550384, PMID 30226009, PMID 31473291, PMID 31804102, PMID 32608505, PMID 32664022, PMID 32852553, PMID 32853005, PMID 32880104, PMID 33175470
K23MH001849 (1), K24DK065018 (1), R01AR047298 (1), R01CA174683 (1), R01CA214647 (1), R01CA239714 (1), R01DA013759 (1), R01DA018954 (1), U10CA095861 (1), UG1CA189955 (1), UG1CA189961 (1)